genome-wide microarray gene expression data (GenomeDx Inc)
90
Structured Review
GenomeDx Inc
genome-wide microarray gene expression data
Genome Wide Microarray Gene Expression Data, supplied by GenomeDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+gene+expression+experiments/genome+wide+microarray+gene+expression+data/pmc08602290-96-21-33
Average 90 stars, based on 1 article reviews
Genome Wide Microarray Gene Expression Data, supplied by GenomeDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+gene+expression+experiments/genome+wide+microarray+gene+expression+data/pmc08602290-96-21-33
Average 90 stars, based on 1 article reviews
genome-wide microarray gene expression data - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Genome Wide:Article Title: G3BP1 inhibits Cul3 SPOP to amplify AR signaling and promote prostate cancer Article Snippet: We evaluated the probability of metastasis-free survival of primary 1626 PCa patients stratified based on low or high G3BP1 group using genome-wide microarray gene expression data from a clinically available Article Title: G3BP1 inhibits Cul3 SPOP to amplify AR signaling and promote prostate cancer. Article Snippet: We evaluated the probability of metastasis-free survival of primary 1626 PCa patients stratified based on low or high G3BP1 group using genome-wide microarray gene expression data from a clinically available Article Title: Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer Article Snippet: We used the SCaPT model to predict the molecular subclass from a retrospective cohort that included 1,626 patient samples and a prospective cohort that included 6,532 samples using genome-wide microarray gene expression data from a clinically available Microarray:Article Title: G3BP1 inhibits Cul3 SPOP to amplify AR signaling and promote prostate cancer Article Snippet: We evaluated the probability of metastasis-free survival of primary 1626 PCa patients stratified based on low or high G3BP1 group using genome-wide microarray gene expression data from a clinically available Article Title: G3BP1 inhibits Cul3 SPOP to amplify AR signaling and promote prostate cancer. Article Snippet: We evaluated the probability of metastasis-free survival of primary 1626 PCa patients stratified based on low or high G3BP1 group using genome-wide microarray gene expression data from a clinically available Article Title: Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer Article Snippet: We used the SCaPT model to predict the molecular subclass from a retrospective cohort that included 1,626 patient samples and a prospective cohort that included 6,532 samples using genome-wide microarray gene expression data from a clinically available Gene Expression:Article Title: G3BP1 inhibits Cul3 SPOP to amplify AR signaling and promote prostate cancer Article Snippet: We evaluated the probability of metastasis-free survival of primary 1626 PCa patients stratified based on low or high G3BP1 group using genome-wide microarray gene expression data from a clinically available Article Title: G3BP1 inhibits Cul3 SPOP to amplify AR signaling and promote prostate cancer. Article Snippet: We evaluated the probability of metastasis-free survival of primary 1626 PCa patients stratified based on low or high G3BP1 group using genome-wide microarray gene expression data from a clinically available Article Title: Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer Article Snippet: We used the SCaPT model to predict the molecular subclass from a retrospective cohort that included 1,626 patient samples and a prospective cohort that included 6,532 samples using genome-wide microarray gene expression data from a clinically available |
